Featured

HDFC Bank Share Price Target at Rs 785: Axis Securities

HDFC Bank Share Price Target at Rs 785: Axis Securities

Axis Securities has issued a BUY call on HDFC Bank in its Axis PUNCH series, setting a three-to-six-month target of Rs 785 against a current price of Rs 715 — about 10 percent of upside.

Apple CEO John Ternus Plays Important Role in Design Segment at Tech Major

Apple CEO John Ternus Plays Important Role in Design Segment at Tech Major

Apple CEO John Ternus has assumed an unusually hands-on role in the company’s design operations, effectively becoming its de facto design chief while choosing not to appoint a formal successor to J

America’s AI Advantage Over China Is Narrowing: Bloomberg Intelligence Report

America’s AI Advantage Over China Is Narrowing: Bloomberg Intelligence Report

The gap between the leading artificial intelligence models developed in the United States and China has narrowed to its smallest level on record, according to Bloomberg Intelligence.

OpenAI launches Always-on AI agents in ChatGPT Under Dots Project

OpenAI launches Always-on AI agents in ChatGPT Under Dots Project

OpenAI’s latest product is designed to shift artificial intelligence from a responsive chatbot into a persistent digital worker.

Ethos Limited Share Price Target at Rs 3,360: Axis Securities

Ethos Limited Share Price Target at Rs 3,360: Axis Securities

Axis Securities has reiterated a BUY rating on Ethos, India's largest luxury-watch retailer, with a target of Rs 3,360 against a current price of Rs 2,525 — about 33 percent of upside.

Symbiotec Pharmalab Share Price Target at Rs 1,540: ICICI Securities

Symbiotec Pharmalab Share Price Target at Rs 1,540: ICICI Securities

ICICI Securities has initiated coverage on Symbiotec Pharmalab with a BUY rating and a Conviction Pick tag, setting a 12-month target of Rs 1,540 against a current price of Rs 1,200 — about 28 perc

Pages